I was diagnosed with cholangiocarcinoma, or cancer of the bile duct. As far as cancers go, it’s an especially brutal one: The five-year survival rate is around 10 percent, and most people diagnosed ...

Adoption rose dramatically as markup margins increased with cost-reimbursement mismatch ...

In the fall of 2022, when I was 42 and living with my wife and three young kids in a small town in northwest Minnesota, a specialist at an unfamiliar hospital approached us with some test results. He ...

Strengthened Executive Leadership. In February 2026, Foghorn appointed Ryan Maynard as Chief Financial Officer. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial ...

AI-powered digital workflow brings greater consistency, efficiency, and collaboration to bone marrow morphologyCellaVision today announced the launch of the CellaVision® Bone Marrow Aspirate (BMA) ...

A pediatrician examining Annie Smith's older brother noticed a bruise on the 6-year-old's leg - which led to a rare and harrowing diagnosis.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Full Circles Therapeutics today announced that its circular single-stranded DNA (cssDNA, C4DNAtm) technology platform has been highlighted as a key enabling component of a new genome engineering ...

A new study finds that a significant portion of older adults with mild cognitive impairment or dementia develop new cardiovascular diagnoses each year ...

Curis is back in focus as analysts reaffirm a $14.00 per share fair value, holding the line on their headline price target even as they revisit the assumptions underneath it. Rather than moving that ...

F10 Antiseptic Wound Spray with Insecticide received the EUA based on scientific evidence available. The FDA announced earlier this week it issued an Emergency Use Authorization (EUA) for benzalkonium ...